Skyrizi on Blue Rx PDP Complete (S5593-003)
risankizumab
Covered, with prior authorization required.
Tier 5 (specialty tier). Quantity limit of 1 per 84 days.
$1,913.41
Patient pays / month, after deductible
$2,063.41
Patient pays / month, before the $200.00 deductible
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
SKYRIZI 150 mg/mL Injection at a preferred retail pharmacy, from the plan's negotiated price of $7,653.65 for a month. Other covered strengths are listed below.
Prior authRequired on all 4 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 4 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| SKYRIZI 150 mg/mL Injection | 5 | $1,913.41 | PA · 1 per 84 days |
| SKYRIZI Kit | 5 | $2,856.91 | PA · 1.2 per 56 days |
| SKYRIZI Kit | 5 | $2,211.43 | PA · 2.4 per 56 days |
| SKYRIZI 150 mg/mL Injection | 5 | $1,918.58 | PA · 1 per 84 days |
Other IL-17 and IL-23 biologics on this plan
Verify with the plan before prescribing or filling. Member services: (800)290-3914. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s5593-003